Bruce J Brew neurologist
Brew, Bruce James
Brew, Bruce.
VIAF ID: 254861733 (Personal)
Permalink: http://viaf.org/viaf/254861733
Preferred Forms
- 100 1 _ ‡a Brew, Bruce
- 100 1 _ ‡a Brew, Bruce
- 100 1 _ ‡a Brew, Bruce James
- 100 1 _ ‡a Brew, Bruce James
- 100 1 _ ‡a Brew, Bruce James
-
-
- 100 0 _ ‡a Bruce J Brew ‡c neurologist
4xx's: Alternate Name Forms (4)
5xx's: Related Names (1)
- 551 _ _ ‡a Sydney ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
Works
Title | Sources |
---|---|
HIV neurology | |
Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone | |
Incidence and prevalence of NMOSD in Australia and New Zealand. | |
Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment | |
Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus | |
Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO). | |
The involvement of astrocytes and kynurenine pathway in Alzheimer's disease. | |
Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis. | |
Is specific HIV eradication from the brain possible or needed? | |
Is the HIV Dementia Scale a Reliable Tool for Assessing HIV-related Neurocognitive Decline? | |
Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review | |
The kynurenine pathway in stem cell biology. | |
Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity. | |
Lead dysregulates serine/threonine protein phosphatases in human neurons. | |
Lost in translation: again, another failed neuroprotection trial. | |
Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not | |
Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. | |
Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy | |
Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification | |
Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria | |
Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance | |
Neural transplantation of human MSC and NT2 cells in the twitcher mouse model. | |
NeuroAIDS in the Asia Pacific Region. | |
Neurodegeneration and ageing in the HAART era. | |
The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis. | |
NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials | |
No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts. | |
The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes | |
Participants' perspectives of self-collected anal cytological swabs | |
The pathogenesis and treatment of HIV CNS infection, 1998: | |
Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo | |
Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition | |
Possible JCV granular cell neuronopathy in a patient with HIV infection | |
Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report | |
The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication. | |
Preface | |
Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. | |
Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. | |
Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies | |
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. | |
The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia. | |
The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults. | |
A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review. | |
Serotonin decreases HIV-1 replication in primary cultures of human macrophages through 5-HT(1A) receptors | |
Short Communication: Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy? | |
Statistical integration of 1H NMR and MRS data from different biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection | |
Strategies to target HIV-1 in the central nervous system. | |
Symptoms of depression and rates of neurocognitive impairment in HIV positive patients in Beijing, China. | |
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of | |
Tissue-Specific Sequence Alterations in the Human Immunodeficiency Virus Type 1 Envelope Favoring CCR5 Usage Contribute to Persistence of Dual-Tropic Virus in the Brain | |
Transcriptional activity of blood-and cerebrospinal fluid-derived nef/long-terminal repeat sequences isolated from a slow progressor infected with nef-deleted human immunodeficiency virus type 1 (HIV-1) who developed HIV-associated dementia | |
Treatment of opportunistic infections and lymphoma in the nervous system | |
Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab. | |
Understanding the roles of the kynurenine pathway in multiple sclerosis progression. | |
Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients | |
Undifferentiated mouse mesenchymal stem cells spontaneously express neural and stem cell markers Oct-4 and Rex-1. | |
Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study. | |
Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. | |
Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm | |
Vestibular symptoms as the presenting feature of progressive supranuclear palsy. | |
White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration | |
Zawroty głowy u osoby z HIV | |
মুখবন্ধ |